230 related articles for article (PubMed ID: 20736062)
1. SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery.
Liang HL; Sedlic F; Bosnjak Z; Nilakantan V
Free Radic Biol Med; 2010 Nov; 49(10):1550-60. PubMed ID: 20736062
[TBL] [Abstract][Full Text] [Related]
2. Partial attenuation of cytotoxicity and apoptosis by SOD1 in ischemic renal epithelial cells.
Liang HL; Arsenault J; Mortensen J; Park F; Johnson CP; Nilakantan V
Apoptosis; 2009 Oct; 14(10):1176-89. PubMed ID: 19685188
[TBL] [Abstract][Full Text] [Related]
3. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes.
Abdallah Y; Kasseckert SA; Iraqi W; Said M; Shahzad T; Erdogan A; Neuhof C; Gündüz D; Schlüter KD; Tillmanns H; Piper HM; Reusch HP; Ladilov Y
J Cell Mol Med; 2011 Nov; 15(11):2478-85. PubMed ID: 21199327
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.
Szeto HH; Liu S; Soong Y; Wu D; Darrah SF; Cheng FY; Zhao Z; Ganger M; Tow CY; Seshan SV
J Am Soc Nephrol; 2011 Jun; 22(6):1041-52. PubMed ID: 21546574
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-derived superoxide links to tourniquet-induced apoptosis in mouse skeletal muscle.
Tran TP; Tu H; Liu J; Muelleman RL; Li YL
PLoS One; 2012; 7(8):e43410. PubMed ID: 22912870
[TBL] [Abstract][Full Text] [Related]
6. Selective mitochondrial antioxidant MitoTEMPO reduces renal dysfunction and systemic inflammation in experimental sepsis in rats.
Arulkumaran N; Pollen SJ; Tidswell R; Gaupp C; Peters VBM; Stanzani G; Snow TAC; Duchen MR; Singer M
Br J Anaesth; 2021 Oct; 127(4):577-586. PubMed ID: 34332740
[TBL] [Abstract][Full Text] [Related]
7. Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytes.
Lozano O; Silva-Platas C; Chapoy-Villanueva H; Pérez BE; Lees JG; Ramachandra CJA; Contreras-Torres FF; Lázaro-Alfaro A; Luna-Figueroa E; Bernal-Ramírez J; Gordillo-Galeano A; Benitez A; Oropeza-Almazán Y; Castillo EC; Koh PL; Hausenloy DJ; Lim SY; García-Rivas G
Part Fibre Toxicol; 2020 May; 17(1):15. PubMed ID: 32381100
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.
Loor G; Kondapalli J; Iwase H; Chandel NS; Waypa GB; Guzy RD; Vanden Hoek TL; Schumacker PT
Biochim Biophys Acta; 2011 Jul; 1813(7):1382-94. PubMed ID: 21185334
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons.
Hu H; Li M
Biochem Biophys Res Commun; 2016 Sep; 478(1):174-180. PubMed ID: 27444386
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial alterations in livers of Sod1-/- mice fed alcohol.
Kessova IG; Cederbaum AI
Free Radic Biol Med; 2007 May; 42(10):1470-80. PubMed ID: 17448893
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial permeability transition and its regulatory components are implicated in apoptosis of primary cultures of rat proximal tubular cells exposed to lead.
Liu G; Wang ZK; Wang ZY; Yang DB; Liu ZP; Wang L
Arch Toxicol; 2016 May; 90(5):1193-209. PubMed ID: 26082307
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor Receptor-Associated Protein 1 Protects against Mitochondrial Injury by Preventing High Glucose-Induced mPTP Opening in Diabetes.
Liu L; Zhang L; Zhao J; Guo X; Luo Y; Hu W; Zhao T
Oxid Med Cell Longev; 2020; 2020():6431517. PubMed ID: 32215175
[TBL] [Abstract][Full Text] [Related]
14. A transient increase in lipid peroxidation primes preadipocytes for delayed mitochondrial inner membrane permeabilization and ATP depletion during prolonged exposure to fatty acids.
Rogers C; Davis B; Neufer PD; Murphy MP; Anderson EJ; Robidoux J
Free Radic Biol Med; 2014 Feb; 67():330-41. PubMed ID: 24269897
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury.
Patil NK; Parajuli N; MacMillan-Crow LA; Mayeux PR
Am J Physiol Renal Physiol; 2014 Apr; 306(7):F734-43. PubMed ID: 24500690
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E protects against the mitochondrial damage caused by cyclosporin A in LLC-PK1 cells.
de Arriba G; de Hornedo JP; Rubio SR; Fernández MC; Martínez SB; Camarero MM; Cid TP
Toxicol Appl Pharmacol; 2009 Sep; 239(3):241-50. PubMed ID: 19523970
[TBL] [Abstract][Full Text] [Related]
17. MitoTEMPO Prevents Oxalate Induced Injury in NRK-52E Cells via Inhibiting Mitochondrial Dysfunction and Modulating Oxidative Stress.
Zhang J; Wang Q; Xu C; Lu Y; Hu H; Qin B; Wang Y; He D; Li C; Yu X; Wang S; Liu J
Oxid Med Cell Longev; 2017; 2017():7528090. PubMed ID: 28116040
[TBL] [Abstract][Full Text] [Related]
18. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Lu N; Sun Y; Zheng X
Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
[TBL] [Abstract][Full Text] [Related]
19. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
